InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Jean-Marie Lefèvre, 董事长. Officer active across 1 company, notably MAAT PHARMA. Aggregated, 1 disclosures have been recorded. History available since 17 February 2023. The latest transaction was disclosed on 17 February 2023 (Souscription). Regulator: AMF. All data is openly available.
Companies and markets linked to Jean-Marie Lefèvre
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
250,000 股@ €8.00100.0% 占其流量ActionEuronext ParisISIN FR00126348222023DD885900
1 条申报中的 1 条
About Jean-Marie Lefèvre
Jean-Marie Lefèvre is the Chairman of the Board at Maat Pharma. In this role, he oversees the activities of the board and ensures the good governance of the company. His experience in the pharmaceutical sector allows him to guide the company in its strategic decisions and ensure compliance with current regulations. He plays a key role in the future direction of Maat Pharma.
